Effects of anaesthetic agents on natural killer cells during ovarian surgery.
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2021/07/034915
- Lead Sponsor
- S Seetheraman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1&2
Stage 3 Epithelial ovarian cancer
Exclusion Criteria
Age >70
ASA 3&4
Secondary Cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantify the dynamic changes in CD56 CD3 and HIF 1alpha <br/ ><br>Timepoint: Before induction of anesthesia, <br/ ><br>After induction of anesthesia <br/ ><br>2 hrs after surgical incision <br/ ><br>
- Secondary Outcome Measures
Name Time Method Disease free survivalTimepoint: 3 years from the day of surgery